Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, ...
Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with advanced non-small cell lung cancer (NSCLC) treated with ...
A new clinical trial led by the Alliance for Clinical Trials in Oncology will investigate if a combination of drug therapies ...
The International Association of Top Professionals (IAOTP) will honor Dr. Alan Hartford at their annual awards gala in ...
The initiative now includes Foundation Medicine's FoundationOne Liquid CDx assay to test new therapy combinations in select groups of adults and children with cancer.
aDepartment of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA bDepartment of Obstetrics, Gynecology, and Women's Health, University of ...
PORTLAND, Ore. (KOIN) — The USA Climbing 2026 National Team Trials will get underway in Beaverton tomorrow. Several climbers are set to compete for a chance to represent the United States in this year ...
Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...
This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...
Japan’s health ministry has endorsed issuing conditional approval for two first-of-a-kind medicines. But some researchers say that the therapies — made from reprogrammed stem cells and called Amchepry ...
A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results